RORγt inverse agonist 13 |
カタログ番号GC62349 |
RORγt インバース アゴニスト 13 (化合物 3i) は、強力な経口活性および選択的 RORγt インバース アゴニストであり、改善された薬物様特性を持ち、IC50 は 63.8 nM です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170477-75-3
Sample solution is provided at 25 µL, 10mM.
RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist, with improved drug-like properties, with an IC50 of 63.8 nM[1].
RORγt inverse agonist 13 (Compound 3i) exhibits activity with an inhibition of 76% at 0.3 µM in Th17 cell differentiation assay[1].
RORγt inverse agonist 13 (Compound 3i, 25 mg/kg, Orally, twice daily) demonstrats excellent in vivo PK profile in mice and good in vivo efficacy in an IMQ-induced psoriasis mice model[1].
[1]. Nannan Sun, et al. Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists. Eur J Med Chem. 2020 Jul 5;202:112536.
Average Rating: 5
(Based on Reviews and 13 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *